首页 › 基金 › Redmile Group, LLC › SLN
Redmile Group, LLC 对 SLN 的持仓历史
SILENCE THERAPEUTICS PLC · 医疗保健
Redmile Group, LLC 在 Q2 2026 的 13F 申报中披露持有 SLN(SILENCE THERAPEUTICS PLC)2,164,777 股,市值约 US$23.8M,约占其申报组合的 1.60%,在其申报持仓中市值排名第 15 位。 Redmile Group, LLC 最近 10 个申报季度中有 10 个季度披露了 SLN 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Redmile Group, LLC 对 SLN 的持仓演变
Redmile Group, LLC 于 Q1 2024 首次披露 SLN 持仓:2,027,669 股(约 US$43.8M)。 在 10 次申报中,Redmile Group, LLC 1 次增持、4 次减持、4 次保持不变。 最近一期申报(Q2 2026)显示持股 2,164,777 股、市值约 US$23.8M。 持仓曾出现大幅变动:Q4 2024 增持约 26% (随后一个季度股价下跌 59%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 2.03M | $43.80M | 新进 |
| Q2 2024 | 2.01M | $38.27M | 减持 |
| Q3 2024 | 1.90M | $34.53M | 减持 |
| Q4 2024 | 2.40M | $16.51M | 增持 |
| Q1 2025 | 2.21M | $6.25M | 减持 |
| Q2 2025 | 2.16M | $12.56M | 减持 |
| Q3 2025 | 2.16M | $11.24M | 持有 |
| Q4 2025 | 2.16M | $13.16M | 持有 |
| Q1 2026 | 2.16M | $11.41M | 持有 |
| Q2 2026 | 2.16M | $23.77M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SLN 与 13F 数据
SLN(SILENCE THERAPEUTICS PLC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 SLN,申报仓位最大的包括:Siren, L.L.C. (US$36.4M), TCG Crossover Management, LLC (US$33.3M), Nantahala Capital Management, LLC (US$14.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SLN 的基金
- Siren, L.L.C. 3.31M 股 · $36.36M · Q2 2026
- TCG Crossover Management, LLC 3.03M 股 · $33.31M · Q2 2026
- Nantahala Capital Management, LLC 1.35M 股 · $14.79M · Q2 2026
- Nextech Invest Ltd. 952.40K 股 · $10.46M · Q2 2026
- 5AM Venture Management, LLC 476.20K 股 · $5.23M · Q2 2026
- GREAT POINT PARTNERS LLC 450.00K 股 · $4.94M · Q2 2026
- Tetragon Partners GP Ltd 300.00K 股 · $3.29M · Q2 2026
- Ishara Investments LP 55.35K 股 · $2.43M · Q2 2026
- Propel Bio Management, LLC 191.73K 股 · $2.11M · Q2 2026
- M28 Capital Management LP 101.20K 股 · $1.11M · Q2 2026
更多关于 Redmile Group, LLC
常见问题
How long has Redmile Group, LLC held SLN?
Redmile Group, LLC has disclosed SLN holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is Redmile Group, LLC's current position in SLN?
As of Q2 2026, Redmile Group, LLC holds 2.16M shares of SLN (SILENCE THERAPEUTICS PLC), valued at $23.77M, representing 1.60% of its reported portfolio and ranking #15.
Has Redmile Group, LLC been buying or selling SLN?
In the latest 13F filing (Q2 2026), Redmile Group, LLC held unchanged its position in SLN.
Which other funds hold SLN?
Other major institutional holders of SLN include Siren, L.L.C., TCG Crossover Management, LLC, Nantahala Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.